Literature DB >> 14979792

m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor.

Paul S Frankel1, Kathryn A Cunningham.   

Abstract

Agonists acting at the serotonin-1B receptor (5-HT1BR) and 5-HT2CR have been reported to potentiate and block, respectively, the discriminative stimulus effects of cocaine. The present investigation reassessed the antagonistic effects of the mixed 5-H2C/1BR agonist m-chlorophenylpiperazine (mCPP) on the discriminative stimulus effects of cocaine in the presence or absence of selective antagonism of the 5-HT1BR or 5-HT2CR. The stimulus effects of cocaine were attenuated by mCPP at doses that reduced response rates. The selective 5-HT2CR antagonist SB 242084, but not the selective 5-HT1BR antagonist GR 127935, reversed the mCPP-evoked attenuation of the cocaine cue and the suppression of response rates. These results demonstrate that the suppressive effects of mCPP on cocaine discrimination are related to stimulation of the HT2CR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14979792     DOI: 10.1037/0735-7044.118.1.157

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  13 in total

1.  Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors.

Authors:  Daniela Rüedi-Bettschen; Roger D Spealman; Donna M Platt
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

2.  Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor.

Authors:  Christopher T Wild; Joanna M Miszkiel; Eric A Wold; Claudia A Soto; Chunyong Ding; Rachel M Hartley; Mark A White; Noelle C Anastasio; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-04-13       Impact factor: 7.446

3.  Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients.

Authors:  Ashwin A Patkar; Paolo Mannelli; Kathleen Peindl; Kevin P Hill; Raman Gopalakrishnan; Wade H Berrettini
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

Review 4.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

5.  Comparing the utility of homogeneous subtypes of cocaine use and related behaviors with DSM-IV cocaine dependence as traits for genetic association analysis.

Authors:  Jinbo Bi; Joel Gelernter; Jiangwen Sun; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-12-11       Impact factor: 3.568

6.  The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.

Authors:  Paul J Fletcher; Judy Sinyard; Guy A Higgins
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

Review 7.  Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Authors:  Leonard L Howell; Kathryn A Cunningham
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.

Authors:  Daniel F Manvich; Heather L Kimmel; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-02-10       Impact factor: 4.030

Review 9.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism.

Authors:  Steven M Graves; Mary J Clark; John R Traynor; Xiu-Ti Hu; T Celeste Napier
Journal:  Neuropharmacology       Date:  2014-09-16       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.